Search
Elementsuche
Struktursuche
Thermo Scientific Chemicals
Fluoxetine hydrochloride, 99%
A selective serotonin reuptake inhibitor | CAS: 56296-78-7 | C17H19ClF3NO | 345.79 g/mol
Have Questions?
Ansicht ändern
Katalognummer J61197.MF
auch als J61197-MF bezeichnet
Preis (EUR)
167,00
Each
Menge:
50 mg
Preis (EUR)
167,00
Each
Chemikalien-Kennzeichnungen
CAS56296-78-7
IUPAC Namehydrogen methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine chloride
Molecular FormulaC17H19ClF3NO
InChI KeyGIYXAJPCNFJEHY-UHFFFAOYNA-N
SMILES[H+].[Cl-].CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
Mehr anzeigen
Specifications
Datenblatt
DatenblattAppearance (Color)White
Assay from Supplier's CofA≥98.5% (HPLC)
FormCrystalline powder
Fluoxetine hydrochloride is a selective serotonin reuptake inhibitor. It is used to treat major depressive disorder, bulimia nervosa (an eating disorder) obsessive-compulsive disorder, panic disorder and premenstrual dysphoric disorder (PMDD).
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.
Applications
Fluoxetine hydrochloride is a selective serotonin reuptake inhibitor. It is used to treat major depressive disorder, bulimia nervosa (an eating disorder) obsessive-compulsive disorder, panic disorder and premenstrual dysphoric disorder (PMDD).
Solubility
Soluble in dimethylsulfoxide and water.
Notes
Incompatible with strong oxidizing agents.
Fluoxetine hydrochloride is a selective serotonin reuptake inhibitor. It is used to treat major depressive disorder, bulimia nervosa (an eating disorder) obsessive-compulsive disorder, panic disorder and premenstrual dysphoric disorder (PMDD).
Solubility
Soluble in dimethylsulfoxide and water.
Notes
Incompatible with strong oxidizing agents.
RUO – Research Use Only
General References:
- Huang, C.; Seip, K. F.; Gjelstad, A.; Shen, X.; Pedersen-Bjergaard, S. Combination of Electromembrane Extraction and Liquid-Phase Microextraction in a Single Step: Simultaneous Group Separation of Acidic and Basic Drugs. Anal. Chem. 2015, 87 (13), 6951-6957.
- Chakravarty, P.; Kothari, S.; Deese, A.; Lubach. J. W. Solid-State Characterization of Novel Propylene Glycol Ester Solvates Isolated from Lipid Formulations. Mol. Pharmaceutics. 2015, 12 (7), 2551-2557.